TP 110

Known as: TP-110, TP110 compound 
 

Topic mentions per year

Topic mentions per year

1986-2009
01219862009

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
TP-110, a novel proteasome inhibitor, has been found to possess potent growth inhibition in human multiple myeloma cells. To… (More)
Is this relevant?
2009
2009
TP-110, a new proteasome inhibitor, has previously shown potent growth inhibition in various tumor cell lines. In this study, the… (More)
Is this relevant?
2009
2009
Boronic acid derivatives of tyropeptin were synthesized with TP-110 as the lead compound. Due to the lability of the aminoboronic… (More)
Is this relevant?
2007
2007
Proteasome inhibitors are useful in the treatment of cancer. Recently, we found a new proteasome inhibitor, TP-110, derived from… (More)
Is this relevant?
2005
2005
Tyropeptin A, a potent proteasome inhibitor, was isolated from the culture broth of Kitasatospora sp. MK993-dF2. We synthesized… (More)
Is this relevant?
2005
2005
Tyropeptin A, a new potent proteasome inhibitor, was produced by Kitasatospora sp. MK993-dF2. To enhance the inhibitory potency… (More)
Is this relevant?
1986
1986
This paper describes an experiment in which it was determined that properly designed burn-in can not only eliminate a weak… (More)
  • table 1
  • figure 1
Is this relevant?